ropivacaine has been researched along with Cicatrix in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, CS; Lu, Q; Luo, C; Ma, X; Sun, H; Sun, P; Yu, JM | 1 |
| Liu, L; Liu, X; Wang, LZ; Xiao, F; Xu, WP; Zhang, YF | 1 |
| Corso, OH; Hewett, PJ; Karatassas, A; Morris, RG | 1 |
3 trial(s) available for ropivacaine and Cicatrix
| Article | Year |
|---|---|
The dose response of sufentanil as an adjuvant to ropivacaine in cesarean section for relief from somato-visceral pain under epidural anesthesia in parturients with scarred uterus.
Topics: Adjuvants, Anesthesia; Adult; Amides; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthetics, Local; Cesarean Section; Cicatrix; Double-Blind Method; Female; Humans; Pregnancy; Prospective Studies; Ropivacaine; Sufentanil; Treatment Outcome; Uterus; Visceral Pain | 2018 |
The Dose-response of Intrathecal Ropivacaine Co-administered with Sufentanil for Cesarean Delivery under Combined Spinal-epidural Anesthesia in Patients with Scarred Uterus.
Topics: Adult; Amides; Anesthesia, Epidural; Anesthesia, Spinal; Cesarean Section; Cicatrix; Dose-Response Relationship, Drug; Female; Humans; Pregnancy; Ropivacaine; Sufentanil; Uterus | 2015 |
Safety of 96-hour incision-site continuous infusion of ropivacaine for postoperative analgesia after bowel cancer resection.
Topics: Aged; Aged, 80 and over; Amides; Analgesia, Patient-Controlled; Anesthetics, Local; Australia; Cicatrix; Colectomy; Colonic Neoplasms; Drug Monitoring; Female; Fentanyl; Humans; Infusions, Parenteral; Length of Stay; Male; Morphine; Orosomucoid; Pain, Postoperative; Postoperative Care; Postoperative Complications; Ropivacaine; Time Factors; Treatment Outcome | 2007 |